| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $169,665 | 34 | 100 |
Sells | $0 | 0 | 0 |
| STERTZER SIMON H | director | 2 | $103,584 | 0 | $0 | $103,584 |
| Altman Peter | President and CEO | 32 | $66,081 | 0 | $0 | $66,081 |
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program, also targeting cardiac and pulmonary conditions. The company is further exploring a specific allogeneic cell therapeutic platform. …
Over the last 12 months, insiders at BioCardia, Inc. have bought $169,665 and sold $0 worth of BioCardia, Inc. stock.
On average, over the past 5 years, insiders at BioCardia, Inc. have bought $795,684 and sold $31,164 worth of stock each year.
Highest buying activity among insiders over the last 12 months: STERTZER SIMON H (director) — $103,584. Altman Peter (President and CEO) — $66,081.
The last purchase of 300 shares for transaction amount of $285 was made by Altman Peter (President and CEO) on 2026‑10‑16.
| 2026-10-16 | Altman Peter | President and CEO | 300 0.002% | $0.95 | $285 | +0.16% | ||
| 2026-10-15 | Altman Peter | President and CEO | 200 0.0013% | $0.95 | $190 | -1.81% | ||
| 2026-09-29 | Altman Peter | President and CEO | 1,000 0.0067% | $1.03 | $1,030 | -8.02% | ||
| 2026-09-23 | Altman Peter | President and CEO | 1,900 0.0128% | $1.05 | $1,995 | -5.69% | ||
| 2026-09-03 | Altman Peter | President and CEO | 800 0.0054% | $1.09 | $872 | -4.59% | ||
| 2026-08-17 | Altman Peter | President and CEO | 5,400 0.0442% | $0.93 | $5,022 | +11.70% | ||
| 2026-08-13 | Altman Peter | President and CEO | 1,900 0.0126% | $0.92 | $1,748 | +11.96% | ||
| 2026-07-29 | Altman Peter | President and CEO | 5,000 0.0869% | $0.78 | $3,900 | +31.83% | ||
| 2026-07-17 | Altman Peter | President and CEO | 500 0.0087% | $0.83 | $415 | +19.96% | ||
| 2026-07-15 | Altman Peter | President and CEO | 1,500 0.0277% | $0.86 | $1,290 | +12.57% | ||
| 2026-07-14 | Altman Peter | President and CEO | 2,800 0.053% | $0.88 | $2,464 | +22.49% | ||
| 2026-07-10 | Altman Peter | President and CEO | 1,000 0.0182% | $0.94 | $940 | +6.94% | ||
| 2026-07-09 | Altman Peter | President and CEO | 1,000 0.0174% | $0.90 | $900 | +9.46% | ||
| 2026-07-08 | Altman Peter | President and CEO | 5,500 0.0953% | $0.97 | $5,335 | +1.06% | ||
| 2026-07-08 | Altman Peter | President and CEO | 5,400 0.0885% | $0.96 | $5,208 | +1.06% | ||
| 2026-06-23 | STERTZER SIMON H | director | 39,000 0.6726% | $1.00 | $39,000 | -0.90% | ||
| 2026-06-22 | STERTZER SIMON H | director | 70,200 1.152% | $0.92 | $64,584 | +2.97% | ||
| 2026-06-18 | Altman Peter | President and CEO | 800 0.0137% | $0.96 | $768 | +2.44% | ||
| 2026-06-17 | Altman Peter | President and CEO | 1,500 0.0232% | $0.85 | $1,275 | +4.54% | ||
| 2026-06-09 | Altman Peter | President and CEO | 5,000 0.0797% | $0.85 | $4,250 | +13.63% |
| Altman Peter | President and CEO | 385385 2.5457% | $355,170.82 | 117 | 0 | <0.0001% |
| STERTZER SIMON H | director | 166338 1.0988% | $153,297.10 | 26 | 0 | <0.0001% |
| Brooks Andrew A | CEO | 63560031 419.8491% | $58.58M | 11 | 0 | |
| BROOKS JONATHAN | director, 10 percent owner | 32045292 211.6768% | $29.53M | 1 | 2 | |
| FROST PHILLIP MD ET AL | 10 percent owner | 1896025 12.5243% | $1.75M | 19 | 2 | |
| Allen Jim L. | director | 668200 4.4138% | $615,813.12 | 1 | 0 | +44.98% |
| Blank Andrew Scott | director | 634023 4.1881% | $584,315.60 | 4 | 0 | <0.0001% |
| McClung David | Chief Financial Officer | 47950 0.3167% | $44,190.72 | 8 | 0 | <0.0001% |
| Morgan Thomas H. | director | 40419 0.267% | $37,250.15 | 3 | 8 | |
| KRASNO RICHARD M | director | 16268 0.1075% | $14,992.59 | 1 | 0 | <0.0001% |
| Facteau Bill | director | 13123 0.0867% | $12,094.16 | 1 | 0 | <0.0001% |
| GERAGHTY KENNETH G | director, 10 percent owner | 6221 0.0411% | $5,733.27 | 2 | 0 | |
| GOTTLIEB CORREY J | director | 3333 0.022% | $3,071.69 | 1 | 0 | |
| MERCORELLA ANTHONY J | director | 333 0.0022% | $306.89 | 1 | 0 | |
| GERSTENBLATT RANDY | director | 66 0.0004% | $60.83 | 1 | 0 | |
| Richards Ronald N. | director | 0 0% | $0 | 1 | 1 |
$18,815,063 | 62 | -6.45% | $13.7M | |
BioCardia, Inc. (BCDA) | $1,993,425 | 46 | -21.91% | $13.95M |
$95,567,744 | 39 | -17.01% | $10.94M | |
$30,257,839 | 29 | -15.72% | $12M | |
$76,600 | 22 | -38.58% | $10.49M |
| Increased Positions | 12 | +80% | 249,071 | +58.32% |
| Decreased Positions | 5 | -33.33% | 26,549 | -6.22% |
| New Positions | 4 | New | 174,386 | New |
| Sold Out Positions | 2 | Sold Out | 20,170 | Sold Out |
| Total Postitions | 22 | +46.67% | 649,615 | +52.1% |
| Cm Management, Llc | $165.00 | 1.18% | 130,000 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $123.00 | 0.88% | 96,498 | +83,614 | +648.98% | 2025-09-30 |
| Susquehanna International Group, Llp | $49.00 | 0.35% | 38,808 | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $49.00 | 0.35% | 38,740 | +1,277 | +3.41% | 2025-09-30 |
| Brown Advisory Inc | $45.00 | 0.32% | 35,538 | 0 | 0% | 2025-09-30 |
| Two Sigma Securities, Llc | $25.00 | 0.18% | 19,337 | +19,337 | New | 2025-09-30 |
| Commonwealth Equity Services, Llc | $23.00 | 0.17% | 18,283 | +200 | +1.11% | 2025-09-30 |
| Wealth Enhancement Advisory Services, Llc | $22.00 | 0.16% | 17,000 | +17,000 | New | 2025-09-30 |
| Xtx Topco Ltd | $21.00 | 0.15% | 16,177 | +16,177 | New | 2025-09-30 |
| Ubs Group Ag | $14.00 | 0.1% | 10,740 | +6,561 | +157% | 2025-09-30 |